Cargando…
SGLT-2 Inhibitors in Heart Failure: A Review of Current Evidence
Sodium-glucose co-transporter 2 (SGLT-2) inhibitors are the latest addition to guideline-directed medical therapy in heart failure (HF) with reduced ejection fraction with recent trials suggesting a significant reduction in adverse cardiovascular outcomes in patients with HF with mildly reduced and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Heart Failure
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172076/ https://www.ncbi.nlm.nih.gov/pubmed/37180562 http://dx.doi.org/10.36628/ijhf.2022.0030 |